C. Cantarel

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

J. Blay, F. Bertucci, C. Sautès-Fridman, 2022, Nature Medicine.

Bone Uptake in Prostate Cancer Patients

C. Merlin, A. Crombé, C. Rousseau, 2022, Clinical nuclear medicine.

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma

M. Toulmonde, A. Italiano, C. Bellera, 2022, Journal of Hematology & Oncology.

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer

M. Toulmonde, A. Italiano, C. Bellera, 2022, Experimental Hematology & Oncology.

Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.

I. Soubeyran, M. Toulmonde, A. Italiano, 2022, European journal of cancer.

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

I. Soubeyran, A. Italiano, C. Bellera, 2021, Clinical Cancer Research.

Regomune: A phase II study of regorafenib + avelumab in solid tumors—Results of the biliary tract cancer (BTC) cohort.

I. Soubeyran, A. Italiano, T. Mazard, 2021 .

PD1 inhibition in soft-tissue sarcomas with tertiary lymphoid structures: A multicenter phase II trial.

J. Blay, F. Bertucci, C. Sautès-Fridman, 2021 .

REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.

I. Soubeyran, M. Toulmonde, A. Italiano, 2020 .

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study

F. Durrieu, S. Mathoulin-Pélissier, I. Soubeyran, 2023, International journal of environmental research and public health.

Incidence and prognostic factors of clinically meaningful toxicities of kinase inhibitors in older patients with cancer: The PreToxE study.

A. Italiano, C. Bellera, E. Paillaud, 2020, Journal of geriatric oncology.

Anastomotic leakage and functional outcomes following total mesorectal excision with delayed and immediate colo-anal anastomosis for rectal cancer: Two single-arm phase II trials.

A. Dupré, E. Rullier, G. Désolneux, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.